Clinical study for collagen metabolism in patients with coronary heart disease and heart failure with Lixinshui prescription

Yancheng Hospital of TCM affiliated to Nanjing University of Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1) Aged 18-80 years, gender is not limited;
•2) Meet the diagnostic criteria for coronary heart disease with heartfailure;
•3) NYHA heart function level II-IV;
•4) Comply with the diagnostic criteria of Chinese medicine heart edema syndrome;
•5) Volunteer participation and signing informed consent.

•1) Acute exacerbation of chronic heart failure or acute heart failure;
•2) Heart failure due to major organ failure such as liver and kidney;
•3) The patient may undergo coronary artery bypass grafting or heart transplant surgery within the next 12 weeks; cardiac resynchronization therapy has been or may be performed;
•4) Patients with severe primary diseases such as liver and kidney and endocrine and hematopoietic systems;
•5) Have mental disorders, or malignant tumors;
•6) Pregnant or pregnant women, lactating women;
•7) Suspicious or clear allergies to the study drug;
•8) Participate in other researchers in the past 2 months;
•9) Factors that can aggravate mortality: such as severe ventricular arrhythmia, cardiogenic shock, complete atrioventricular block, obstructive cardiomyopathy, dilated cardiomyopathy, constrictive pericarditis, pericardial tamponade, hemodynamics Unstable unstable heart valve disease, pulmonary embolism, uncontrolled high blood pressure, and severe lung infections.

发起方

Yancheng Hospital of TCM affiliated to Nanjing University of Chinese Medicine